South Sudan vs Yemen: Pneumococcal conjugate second or third-dose vaccines (PCVc)
South Sudan
27.0%
in 2025
Yemen
39.0%
in 2025
South Sudan rank
163rd
Yemen rank
160th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- South Sudan
- Yemen
How they compare
Yemen currently reports 39.0% against 27.0% in South Sudan, a difference of 12.0%.
That makes Yemen's figure about 1.4 times South Sudan's.
Across all 15 years both countries report, Yemen has been ahead every year.
South Sudan ranks 163rd and Yemen ranks 160th of 194 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 60.0% | 60.0% | Yemen |
| 2020s | 4.5% | 48.7% | 44.2% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), South Sudan or Yemen?
- Yemen, at 39.0% against 27.0% in South Sudan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between South Sudan and Yemen?
- 12.0%, with Yemen ahead.
- How many years of comparable data are there for South Sudan and Yemen?
- 15 years are reported by both, from 2011 to 2025.
- How do South Sudan and Yemen rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- South Sudan ranks 163rd and Yemen ranks 160th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.